Investigation of the Relationship between Vitamin D Deficiency and Vitamin D-Binding Protein Polymorphisms in Severe COVID-19 Patients
Lutfiye Karcıoğlu Batur, Mehmet Dokur, Suna Koç, Mehmet Karabay, Zeyneb Nur Akcay, Ezgi Gunger, Nezih Hekim
Diagnostics, doi:10.3390/diagnostics14171941
This study explores the association of vitamin D-binding protein (VDBP) gene polymorphisms, vitamin D levels, and the severity of COVID-19, including the need for intensive care unit (ICU) hospitalization. We analyzed a cohort of 56 consecutive age-and gender-matched adult COVID-19-positive patients and categorized them into three groups: outpatients with mild illness, inpatients with moderate disease, and ICU patients. We measured levels of free, total, and bioavailable 25hydroxyvitamin D [25(OH)D], VDBP, and albumin. VDBP polymorphisms rs5488 and rs7041 were identified using real-time PCR. A significant proportion of ICU patients were vitamin D-deficient (56.25%) compared to outpatients (10%) and inpatients (5%) (p = 0.0003). ICU patients also had notably lower levels of VDBP (median: 222 mg/L) and total 25(OH)D (median: 18.8 ng/mL). Most patients carried heterozygous rs7041 (60.7%) and wild-type rs4588 (58.9%) genotypes. The distribution of rs7041 SNP varied significantly among groups (p = 0.0301), while rs4588 SNP distribution did not (p = 0.424). Heterozygous rs4588 patients had significantly lower VDBP levels (p = 0.029) and reduced bioavailable 25(OH)D compared to those with wild-type rs4588 (p = 0.020). Our findings indicate that VDBP gene polymorphisms, particularly rs7041 and rs4588, are associated with vitamin D status and the severity of COVID-19. The lower VDBP levels and bioavailable vitamin D in ICU patients suggest that these genetic variants may influence disease severity and hospitalization needs. These results highlight the potential role of VDBP polymorphisms in COVID-19 severity, suggesting that genetic screening could be valuable in assessing the risk of severe outcomes and guiding personalized treatment strategies.
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Conflicts of Interest: The authors declare no conflict of interest.
References
Al-Daghri, Mohammed, Bukhari, Rikli, Abdi et al., Efficacy of vitamin D supplementation according to vitamin D-binding protein polymorphisms, Nutrition,
doi:10.1016/j.nut.2019.02.003
Alharazy, Naseer, Alissa, Robertson, Lanham-New et al., Association of SNPs in GC and CYP2R1 with total and directly measured free 25-hydroxyvitamin D in multi-ethnic postmenopausal women in Saudi Arabia, Saudi J. Biol. Sci,
doi:10.1016/j.sjbs.2021.04.071
Aloia, Mikhail, Dhaliwal, Shieh, Usera et al., Free 25(OH)D and the Vitamin D Paradox in African Americans, J. Clin. Endocrinol. Metab,
doi:10.1210/JC.2015-2066
Apaydin, Polat, Dincer Yazan, Ilgin, Elbasan et al., Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19, Clin. Endocrinol,
doi:10.1111/cen.14664
Arnaud, Constans, Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP), Hum. Genet,
doi:10.1007/BF00219689
Barrea, Verde, Grant, Frias-Toral, Sarno et al., Vitamin D: A Role Also in Long COVID-19?, Nutrients,
doi:10.3390/nu14081625
Batur, Koç, Association between Vitamin D Status and Secondary Infections in Patients with Severe COVID-19 Admitted in the Intensive Care Unit of a Tertiary-Level Hospital in Turkey, Diagnostics,
doi:10.3390/diagnostics13010059
Bikle, Schwartz, Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions, Front. Endocrinol,
doi:10.3389/fendo.2019.00317
Charoenngam, Jaroenlapnopparat, Mettler, Grover, Genetic Variations of the Vitamin D Metabolic Pathway and COVID-19 Susceptibility and Severity: Current Understanding and Existing Evidence, Biomedicines,
doi:10.3390/biomedicines11020400
Delanghe, De Buyzere, Speeckaert, Genetic polymorphisms in the host and COVID-19 infection
Dissanayake, De Silva, Sumanatilleke, De Silva, Gamage et al., Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis, J. Clin. Endocrinol. Metab,
doi:10.1210/clinem/dgab892
Erasmus, Maepa, Machingura, Davids, Raghubeer et al., Vitamin D-Binding Proteins, and VDR Polymorphisms in Individuals with Hyperglycaemia, Nutrients,
doi:10.3390/nu14153147
Faul, Erdfelder, Buchner, Lang, Statistical power analyses using G* Power 3.1: Tests for correlation and regression analyses, Behav. Res. Methods,
doi:10.3758/BRM.41.4.1149
Freitas, Calhau, Antunes, Araújo, Bandeira et al., Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity, Sci. Rep,
doi:10.1038/s41598-021-99952-z
Gibbons, Norton, Mccullough, Meltzer, Lavigne et al., Association between vitamin D supplementation and COVID-19 infection and mortality, Sci. Rep
Hafez, Saleh, Arya, Alzouhbi, Fdl Alla et al., Vitamin D Status in Relation to the Clinical Outcome of Hospitalized COVID-19 Patients, Front. Med,
doi:10.3389/fmed.2022.843737
Jiang, Deng, Zhang, Cai, Cheung et al., Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19), J. Gen. Intern. Med,
doi:10.1007/s11606-020-05762-w
Kahar, Yusrawati, Jamsari, Maskoen, Aribowo et al., Association between Polymorphism Locus rs7041 and rs4588 in VDBP Gene and Vitamin D Status with Mortality in Sepsis Patient, J. Hunan Univ. Nat. Sci,
doi:10.55463/issn.1674-2974.50.2.15
Karcioglu Batur, Hekim, The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate, J. Med. Virol,
doi:10.1002/jmv.26409
Kaya, Pamukçu, Yakar, The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies, Epidemiol. Health,
doi:10.4178/epih.e2021074
Laird, Rhodes, Kenny, Vitamin D and Inflammation: Potential Implications for Severity of COVID-19, Ir. Med. J
Little, Higgins, Ioannidis, Moher, Gagnon et al., STrengthening the REporting of Genetic Association studies (STREGA)-An extension of the STROBE statement, Eur. J. Clin. Investig,
doi:10.1111/j.1365-2362.2009.02125.x
Mariani, Giménez, Bergam, Tajer, Antonietti et al., Association Between Vitamin D Deficiency and COVID-19 Incidence, Complications, and Mortality in 46 Countries: An Ecological Study, Health Secur,
doi:10.1089/hs.2020.0137
Mcgrath, Saha, Burne, Eyles, A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations, J. Steroid Biochem. Mol. Biol,
doi:10.1016/j.jsbmb.2010.03.073
Mondul, Weinstein, Virtamo, Albanes, Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer, Br. J. Cancer,
doi:10.1038/bjc.2012.417
Pereira, Dantas Damascena, Galvão Azevedo, De Almeida Oliveira, Da Mota Santana, Vitamin D deficiency aggravates COVID-19: Systematic review and meta-analysis, Crit. Rev. Food Sci. Nutr,
doi:10.1080/10408398.2020.1841090
Ross, Manson, Abrams, Aloia, Brannon et al., The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know, J. Clin. Endocrinol. Metab,
doi:10.1210/jc.2010-2704
Rozmus, Ciesielska, Płomi Ński, Grzybowski, Fiedorowicz et al., Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases, Int. J. Mol. Sci,
doi:10.3390/ijms21217822
Rozmus, Płomi Ński, Augustyn, Cieśli ńska, A. rs7041 and rs4588 Polymorphisms in Vitamin D Binding Protein Gene (VDBP) and the Risk of Diseases, Int. J. Mol. Sci,
doi:10.3390/ijms23020933
Speeckaert, De Buyzere, Delanghe, Vitamin D binding protein polymorphism and COVID-19, J. Med. Virol,
doi:10.1002/jmv.26508
Thacher, Evaluating the Evidence in Clinical Studies of Vitamin D in COVID-19, Nutrients,
doi:10.3390/nu14030464
Wang, Joshi, Leopold, Jackson, Christensen et al., Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis, Clin. Endocrinol,
doi:10.1111/cen.14540
DOI record:
{
"DOI": "10.3390/diagnostics14171941",
"ISSN": [
"2075-4418"
],
"URL": "http://dx.doi.org/10.3390/diagnostics14171941",
"abstract": "<jats:p>This study explores the association of vitamin D-binding protein (VDBP) gene polymorphisms, vitamin D levels, and the severity of COVID-19, including the need for intensive care unit (ICU) hospitalization. We analyzed a cohort of 56 consecutive age- and gender-matched adult COVID-19-positive patients and categorized them into three groups: outpatients with mild illness, inpatients with moderate disease, and ICU patients. We measured levels of free, total, and bioavailable 25-hydroxyvitamin D [25(OH)D], VDBP, and albumin. VDBP polymorphisms rs5488 and rs7041 were identified using real-time PCR. A significant proportion of ICU patients were vitamin D-deficient (56.25%) compared to outpatients (10%) and inpatients (5%) (p = 0.0003). ICU patients also had notably lower levels of VDBP (median: 222 mg/L) and total 25(OH)D (median: 18.8 ng/mL). Most patients carried heterozygous rs7041 (60.7%) and wild-type rs4588 (58.9%) genotypes. The distribution of rs7041 SNP varied significantly among groups (p = 0.0301), while rs4588 SNP distribution did not (p = 0.424). Heterozygous rs4588 patients had significantly lower VDBP levels (p = 0.029) and reduced bioavailable 25(OH)D compared to those with wild-type rs4588 (p = 0.020). Our findings indicate that VDBP gene polymorphisms, particularly rs7041 and rs4588, are associated with vitamin D status and the severity of COVID-19. The lower VDBP levels and bioavailable vitamin D in ICU patients suggest that these genetic variants may influence disease severity and hospitalization needs. These results highlight the potential role of VDBP polymorphisms in COVID-19 severity, suggesting that genetic screening could be valuable in assessing the risk of severe outcomes and guiding personalized treatment strategies.</jats:p>",
"alternative-id": [
"diagnostics14171941"
],
"author": [
{
"ORCID": "http://orcid.org/0000-0002-4803-9137",
"affiliation": [
{
"name": "Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University, Istanbul 34015, Turkey"
}
],
"authenticated-orcid": false,
"family": "Karcıoğlu Batur",
"given": "Lutfiye",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Department of Emergency Medicine, Medical Faculty, Biruni University, Istanbul 34015, Turkey"
}
],
"family": "Dokur",
"given": "Mehmet",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-1738-8940",
"affiliation": [
{
"name": "Department of Anesthesiology and Reanimation, Medical Faculty, Biruni University, Istanbul 34015, Turkey"
}
],
"authenticated-orcid": false,
"family": "Koç",
"given": "Suna",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Infectious Disease, Private Medicana Hospitalis Bahçelievler, Istanbul 34180, Turkey"
}
],
"family": "Karabay",
"given": "Mehmet",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University, Istanbul 34015, Turkey"
}
],
"family": "Akcay",
"given": "Zeyneb Nur",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University, Istanbul 34015, Turkey"
}
],
"family": "Gunger",
"given": "Ezgi",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University, Istanbul 34015, Turkey"
}
],
"family": "Hekim",
"given": "Nezih",
"sequence": "additional"
}
],
"container-title": "Diagnostics",
"container-title-short": "Diagnostics",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2024,
9,
3
]
],
"date-time": "2024-09-03T08:06:41Z",
"timestamp": 1725350801000
},
"deposited": {
"date-parts": [
[
2024,
9,
3
]
],
"date-time": "2024-09-03T09:16:04Z",
"timestamp": 1725354964000
},
"funder": [
{
"award": [
"Biruni-BAP-2022-01-25"
],
"name": "Biruni University Scientific Research Coordination Unit"
}
],
"indexed": {
"date-parts": [
[
2024,
9,
4
]
],
"date-time": "2024-09-04T00:28:30Z",
"timestamp": 1725409710567
},
"is-referenced-by-count": 0,
"issue": "17",
"issued": {
"date-parts": [
[
2024,
9,
3
]
]
},
"journal-issue": {
"issue": "17",
"published-online": {
"date-parts": [
[
2024,
9
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2024,
9,
3
]
],
"date-time": "2024-09-03T00:00:00Z",
"timestamp": 1725321600000
}
}
],
"link": [
{
"URL": "https://www.mdpi.com/2075-4418/14/17/1941/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "1968",
"original-title": [],
"page": "1941",
"prefix": "10.3390",
"published": {
"date-parts": [
[
2024,
9,
3
]
]
},
"published-online": {
"date-parts": [
[
2024,
9,
3
]
]
},
"publisher": "MDPI AG",
"reference": [
{
"key": "ref_1",
"unstructured": "(2024, June 12). WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int."
},
{
"DOI": "10.1007/s11606-020-05762-w",
"article-title": "Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)",
"author": "Jiang",
"doi-asserted-by": "crossref",
"first-page": "1545",
"journal-title": "J. Gen. Intern. Med.",
"key": "ref_2",
"volume": "35",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)30185-9",
"article-title": "A novel coronavirus outbreak of global health concern",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "470",
"journal-title": "Lancet",
"key": "ref_3",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1080/10408363.2020.1783198",
"article-title": "The COVID-19 pandemic",
"author": "Ciotti",
"doi-asserted-by": "crossref",
"first-page": "365",
"journal-title": "Crit. Rev. Clin. Lab. Sci.",
"key": "ref_4",
"volume": "57",
"year": "2020"
},
{
"DOI": "10.3389/fendo.2019.00317",
"doi-asserted-by": "crossref",
"key": "ref_5",
"unstructured": "Bikle, D.D., and Schwartz, J. (2019). Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions. Front. Endocrinol., 10."
},
{
"DOI": "10.3389/fmed.2022.843737",
"doi-asserted-by": "crossref",
"key": "ref_6",
"unstructured": "Hafez, W., Saleh, H., Arya, A., Alzouhbi, M., Fdl Alla, O., Lal, K., Kishk, S., Ali, S., Raghu, S., and Elgaili, W. (2022). Vitamin D Status in Relation to the Clinical Outcome of Hospitalized COVID-19 Patients. Front. Med., 9."
},
{
"DOI": "10.3390/ijms23020933",
"doi-asserted-by": "crossref",
"key": "ref_7",
"unstructured": "Rozmus, D., Płomiński, J., Augustyn, K., and Cieślińska, A. (2022). rs7041 and rs4588 Polymorphisms in Vitamin D Binding Protein Gene (VDBP) and the Risk of Diseases. Int. J. Mol. Sci., 23."
},
{
"article-title": "Efficacy of vitamin D supplementation according to vitamin D-binding protein polymorphisms",
"author": "Mohammed",
"first-page": "148",
"journal-title": "Nutrition",
"key": "ref_8",
"volume": "63–64",
"year": "2019"
},
{
"DOI": "10.1016/j.sjbs.2021.04.071",
"article-title": "Association of SNPs in GC and CYP2R1 with total and directly measured free 25-hydroxyvitamin D in multi-ethnic postmenopausal women in Saudi Arabia",
"author": "Alharazy",
"doi-asserted-by": "crossref",
"first-page": "4626",
"journal-title": "Saudi J. Biol. Sci.",
"key": "ref_9",
"volume": "28",
"year": "2021"
},
{
"DOI": "10.3390/ijms21217822",
"doi-asserted-by": "crossref",
"key": "ref_10",
"unstructured": "Rozmus, D., Ciesielska, A., Płomiński, J., Grzybowski, R., Fiedorowicz, E., Kordulewska, N., Savelkoul, H., Kostyra, E., and Cieślińska, A. (2020). Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms—The Risk of Malignant Tumors and Other Diseases. Int. J. Mol. Sci., 21."
},
{
"DOI": "10.1016/j.jsbmb.2010.03.073",
"article-title": "A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations",
"author": "McGrath",
"doi-asserted-by": "crossref",
"first-page": "471",
"journal-title": "J. Steroid Biochem. Mol. Biol.",
"key": "ref_11",
"volume": "121",
"year": "2010"
},
{
"DOI": "10.1002/jmv.26409",
"article-title": "The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate",
"author": "Hekim",
"doi-asserted-by": "crossref",
"first-page": "1409",
"journal-title": "J. Med. Virol.",
"key": "ref_12",
"volume": "93",
"year": "2021"
},
{
"DOI": "10.3390/nu14030464",
"doi-asserted-by": "crossref",
"key": "ref_13",
"unstructured": "Thacher, T.D. (2022). Evaluating the Evidence in Clinical Studies of Vitamin D in COVID-19. Nutrients, 14."
},
{
"DOI": "10.3390/nu14081625",
"doi-asserted-by": "crossref",
"key": "ref_14",
"unstructured": "Barrea, L., Verde, L., Grant, W.B., Frias-Toral, E., Sarno, G., Vetrani, C., Ceriani, F., Garcia-Velasquez, E., Contreras-Briceño, J., and Savastano, S. (2022). Vitamin D: A Role Also in Long COVID-19?. Nutrients, 14."
},
{
"DOI": "10.3390/diagnostics13010059",
"doi-asserted-by": "crossref",
"key": "ref_15",
"unstructured": "Batur, L.K., and Koç, S. (2022). Association between Vitamin D Status and Secondary Infections in Patients with Severe COVID-19 Admitted in the Intensive Care Unit of a Tertiary-Level Hospital in Turkey. Diagnostics, 13."
},
{
"DOI": "10.1089/hs.2020.0137",
"article-title": "Association Between Vitamin D Deficiency and COVID-19 Incidence, Complications, and Mortality in 46 Countries: An Ecological Study",
"author": "Mariani",
"doi-asserted-by": "crossref",
"first-page": "302",
"journal-title": "Health Secur.",
"key": "ref_16",
"volume": "19",
"year": "2021"
},
{
"article-title": "Vitamin D and Inflammation: Potential Implications for Severity of COVID-19",
"author": "Laird",
"first-page": "81",
"journal-title": "Ir. Med. J.",
"key": "ref_17",
"volume": "113",
"year": "2020"
},
{
"DOI": "10.1016/j.jiph.2020.06.021",
"article-title": "Role of vitamin D in preventing of COVID-19 infection, progression and severity",
"author": "Ali",
"doi-asserted-by": "crossref",
"first-page": "1373",
"journal-title": "J. Infect. Public Health",
"key": "ref_18",
"volume": "1",
"year": "2020"
},
{
"DOI": "10.1111/j.1365-2362.2009.02125.x",
"article-title": "STrengthening the REporting of Genetic Association studies (STREGA)—An extension of the STROBE statement",
"author": "Little",
"doi-asserted-by": "crossref",
"first-page": "247",
"journal-title": "Eur. J. Clin. Investig.",
"key": "ref_19",
"volume": "39",
"year": "2009"
},
{
"DOI": "10.1210/jc.2010-2704",
"article-title": "The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know",
"author": "Ross",
"doi-asserted-by": "crossref",
"first-page": "53",
"journal-title": "J. Clin. Endocrinol. Metab.",
"key": "ref_20",
"volume": "96",
"year": "2011"
},
{
"DOI": "10.1210/JC.2015-2066",
"article-title": "Free 25(OH)D and the Vitamin D Paradox in African Americans",
"author": "Aloia",
"doi-asserted-by": "crossref",
"first-page": "3356",
"journal-title": "J. Clin. Endocrinol. Metab.",
"key": "ref_21",
"volume": "100",
"year": "2015"
},
{
"DOI": "10.1038/bjc.2012.417",
"article-title": "Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer",
"author": "Mondul",
"doi-asserted-by": "crossref",
"first-page": "1589",
"journal-title": "Br. J. Cancer",
"key": "ref_22",
"volume": "107",
"year": "2012"
},
{
"DOI": "10.3758/BRM.41.4.1149",
"article-title": "Statistical power analyses using G* Power 3.1: Tests for correlation and regression analyses",
"author": "Faul",
"doi-asserted-by": "crossref",
"first-page": "1149",
"journal-title": "Behav. Res. Methods",
"key": "ref_23",
"volume": "41",
"year": "2009"
},
{
"DOI": "10.1007/BF00219689",
"article-title": "Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP)",
"author": "Arnaud",
"doi-asserted-by": "crossref",
"first-page": "183",
"journal-title": "Hum. Genet.",
"key": "ref_24",
"volume": "92",
"year": "1993"
},
{
"DOI": "10.1111/cen.14540",
"article-title": "Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "281",
"journal-title": "Clin. Endocrinol.",
"key": "ref_25",
"volume": "96",
"year": "2022"
},
{
"DOI": "10.1080/10408398.2020.1841090",
"article-title": "Vitamin D deficiency aggravates COVID-19: Systematic review and meta-analysis",
"author": "Pereira",
"doi-asserted-by": "crossref",
"first-page": "1308",
"journal-title": "Crit. Rev. Food Sci. Nutr.",
"key": "ref_26",
"volume": "62",
"year": "2022"
},
{
"DOI": "10.1210/clinem/dgab892",
"article-title": "Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis",
"author": "Dissanayake",
"doi-asserted-by": "crossref",
"first-page": "1484",
"journal-title": "J. Clin. Endocrinol. Metab.",
"key": "ref_27",
"volume": "107",
"year": "2022"
},
{
"DOI": "10.4178/epih.e2021074",
"article-title": "The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies",
"author": "Kaya",
"doi-asserted-by": "crossref",
"first-page": "e2021074",
"journal-title": "Epidemiol. Health",
"key": "ref_28",
"volume": "43",
"year": "2021"
},
{
"DOI": "10.1038/s41598-022-24053-4",
"doi-asserted-by": "crossref",
"key": "ref_29",
"unstructured": "Gibbons, J.B., Norton, E.C., McCullough, J.S., Meltzer, D.O., Lavigne, J., Fiedler, V.C., and Gibbons, R.D. (2022). Association between vitamin D supplementation and COVID-19 infection and mortality. Sci. Rep., 12."
},
{
"DOI": "10.3389/fphys.2014.00244",
"doi-asserted-by": "crossref",
"key": "ref_30",
"unstructured": "Wöbke, T.K., Sorg, B.L., and Steinhilber, D. (2014). Vitamin D in inflammatory diseases. Front. Physiol., 5."
},
{
"DOI": "10.1016/j.jaut.2017.07.007",
"article-title": "Modulation of inflammatory and immune responses by Vitamin D",
"author": "Colotta",
"doi-asserted-by": "crossref",
"first-page": "78",
"journal-title": "J. Autoimmun.",
"key": "ref_31",
"volume": "85",
"year": "2017"
},
{
"DOI": "10.1007/978-3-030-63761-3_7",
"doi-asserted-by": "crossref",
"key": "ref_32",
"unstructured": "Delanghe, J.R., De Buyzere, M.L., and Speeckaert, M.M. (2021). Genetic polymorphisms in the host and COVID-19 infection. Coronavirus Disease-COVID-19 2021 May 11, Springer International Publishing."
},
{
"article-title": "Association between Polymorphism Locus rs7041 and rs4588 in VDBP Gene and Vitamin D Status with Mortality in Sepsis Patient",
"author": "Kahar",
"first-page": "150",
"journal-title": "J. Hunan Univ. Nat. Sci.",
"key": "ref_33",
"volume": "50",
"year": "2023"
},
{
"DOI": "10.3390/nu14153147",
"doi-asserted-by": "crossref",
"key": "ref_34",
"unstructured": "Erasmus, R., Maepa, S., Machingura, I., Davids, S., Raghubeer, S., and Matsha, T. (2022). Vitamin D, Vitamin D-Binding Proteins, and VDR Polymorphisms in Individuals with Hyperglycaemia. Nutrients, 14."
},
{
"DOI": "10.1111/cen.14664",
"article-title": "Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19",
"author": "Apaydin",
"doi-asserted-by": "crossref",
"first-page": "819",
"journal-title": "Clin. Endocrinol.",
"key": "ref_35",
"volume": "96",
"year": "2022"
},
{
"DOI": "10.1002/jmv.26508",
"article-title": "Vitamin D binding protein polymorphism and COVID-19",
"author": "Speeckaert",
"doi-asserted-by": "crossref",
"first-page": "705",
"journal-title": "J. Med. Virol.",
"key": "ref_36",
"volume": "93",
"year": "2021"
},
{
"DOI": "10.1038/s41598-021-99952-z",
"doi-asserted-by": "crossref",
"key": "ref_37",
"unstructured": "Freitas, A.T., Calhau, C., Antunes, G., Araújo, B., Bandeira, M., Barreira, S., Bazenga, F., Braz, S., Caldeira, D., and Santos, S.C.R. (2021). Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity. Sci. Rep., 11."
},
{
"DOI": "10.3390/biomedicines11020400",
"doi-asserted-by": "crossref",
"key": "ref_38",
"unstructured": "Charoenngam, N., Jaroenlapnopparat, A., Mettler, S.K., and Grover, A. (2023). Genetic Variations of the Vitamin D Metabolic Pathway and COVID-19 Susceptibility and Severity: Current Understanding and Existing Evidence. Biomedicines, 11."
}
],
"reference-count": 38,
"references-count": 38,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.mdpi.com/2075-4418/14/17/1941"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Investigation of the Relationship between Vitamin D Deficiency and Vitamin D-Binding Protein Polymorphisms in Severe COVID-19 Patients",
"type": "journal-article",
"volume": "14"
}